Patient-Initiated Prostate Cancer Screening Among Older U.S. Men
Authors: Fangjian Guo
Journal: Annals of Internal Medicine (2016)

Letters17 May 2016Patient-Initiated Prostate Cancer Screening Among Older U.S. MenFangjian Guo, MD, PhDFangjian Guo, MD, PhDFrom University of Texas Medical Branch, Galveston, Texas.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/L15-0620 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:Drs. Drazer and Eggener raise an important issue concerning the overuse of PSA tests in older (>70 years) men. We restricted our analysis to men aged 40 to 70 years because the 2008 U.S. Preventive Services Task Force guideline had already recommended against routine PSA screening in older men (1). However, the high screening PSA rate among men aged 75 years or older (2) warrants further investigation in the role of shared decision making in overuse. Here, we assessed the proportion of physician-recommended and patient-initiated screening PSA tests among older men (>70 years) in the United States using ...References1. Moyer VA; U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157:120-34. [PMID: 22801674]. doi:10.7326/0003-4819-157-2-201207170-00459 LinkGoogle Scholar2. Drazer MW, Huo D, Eggener SE. National prostate cancer screening rates after the 2012 US Preventive Services Task Force recommendation discouraging prostate-specific antigen-based screening. J Clin Oncol. 2015;33:2416-23. [PMID: 26056181] doi:10.1200/JCO.2015.61.6532 CrossrefMedlineGoogle Scholar3. Guo F, Hirth JM, Berenson AB. Cervical cancer screening among women = 70 years of age in the United States-A referral problem or patient choice. Prev Med. 2015;81:427-32. [PMID: 26500084] doi:10.1016/j.ypmed.2015.10.005 CrossrefMedlineGoogle Scholar4. Jemal A, Fedewa SA, Ma J, Siegel R, Lin CC, Brawley O, et al. Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations. JAMA. 2015;314:2054-61. [PMID: 26575061] doi:10.1001/jama.2015.14905 CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From University of Texas Medical Branch, Galveston, Texas.Disclosures: The author has disclosed no conflicts of interest. Form can be viewed at www.acponline.org/authors/icmje/ConflictOfInterest Forms.do?msNum=L15-0220. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoThe Roles of Providers and Patients in the Overuse of Prostate-Specific Antigen Screening in the United States Fangjian Guo and Di He Patient-Initiated Prostate Cancer Screening Among Older U.S. Men Michael W. Drazer and Scott E. Eggener Metrics Cited byDiscontinuing Cancer Screening for Older Adults: a Comparison of Clinician Decision-Making for Breast, Colorectal, and Prostate Cancer Screenings 17 May 2016Volume 164, Issue 10Page: 703KeywordsAge groupsCancer screeningConflicts of interestDecision makingDisclosureHealth surveysProstate cancer ePublished: 17 May 2016 Issue Published: 17 May 2016 Copyright & PermissionsCopyright © 2016 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...